Aduhelm approval controversy dials up as FDA seeks probeIn another twist to the Aduhelm approval tale, FDA’s Janet Woodcock has called for an independent investigation into Share XAduhelm approval controversy dials up as FDA seeks probehttps://pharmaphorum.com/news/aduhelm-approval-controversy-dials-up-as-fda-seeks-probe/
Consumer group seeks resignation of top FDA staffers over Aduhelm okayWith the first patient set to receive Biogen’s new Alzheimer’s drug Aduhelm in Rhode Island today, US consumer Share XConsumer group seeks resignation of top FDA staffers over Aduhelm okayhttps://pharmaphorum.com/news/consumer-group-seeks-resignation-of-top-fda-staffers-over-aduhelm-okay/
Biden appoints veteran Woodcock as interim FDA commissionerAgency veteran Dr Janet Woodcock is the new interim FDA commissioner appointed by president Joe Biden to replace Share XBiden appoints veteran Woodcock as interim FDA commissionerhttps://pharmaphorum.com/news/biden-appoints-veteran-woodcock-as-interim-fda-commissioner/
